Market Closed

ZVRA
Zevra Therapeutics
$ 9.08
-18.64%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Zevra Therapeutics News

Latest Zevra Therapeutics Stock News & ZVRA Headlines

Wall Street Analysts Believe Zevra Therapeutics (ZVRA) Could Rally 117.86%: Here's is How to Trade
6 days ago | zacks.com
Zevra Therapeutics, Inc. (ZVRA) Q3 2026 Earnings Call Transcript
11 days ago | seekingalpha.com
Zevra Therapeutics (ZVRA) Q3 Earnings and Revenues Beat Estimates
11 days ago | zacks.com
Zevra Therapeutics Q3 Earnings Call Highlights
11 days ago | marketbeat.com
Zevra Reports Third Quarter 2026 Financial Results and Corporate Update
11 days ago | globenewswire.com
Zevra Therapeutics Announces Details for Q3 2026 Financial Results Call
a month ago | globenewswire.com
Zevra Therapeutics: Cash Plus A Drug Priced Below Its Rival's Deal
a month ago | seekingalpha.com
Zevra Therapeutics: Miplyffa Validates The Bull Case, Europe Still The Swing Factor
a month ago | seekingalpha.com
Zevra Therapeutics, Inc. (ZVRA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
2 months ago | seekingalpha.com
Zevra Therapeutics to Present at Upcoming Investor Conferences
2 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

ZVRA
Zevra Therapeutics
$ 9.08
-18.64%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago